Our SURE™ platform applies a‘Molecule-First, Microbe-Later’strategy: we start with disease-driving metabolites, then tailor strains to modulate them. SURE™ clarifies each strain’s MOA right from the start, turning a normally complex task into a straightforward step, so regulators decide faster and patients benefit sooner.